Added to YB: 2025-07-28
Pitch date: 2025-07-24
FBIO [bullish]
Fortress Biotech, Inc.
-1.55%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally.
Market Cap
$67.7M
Pitch Price
$1.94
Price Target
N/A
Dividend
N/A
EV/EBITDA
1.59
P/E
0.62
EV/Sales
-0.49
Sector
Biotechnology
Category
special_situation
Show full summary:
Fortress Biotech - New all-time high in $FBIOP shares & size in the stock portfolio
FBIO (added to position): Still bullish despite CAEL-101 setback. Reinstated dividend likely by Mar 2026 via: 1) Strong EMROSI sales 2) CUTX-101 FDA approval/PRV or 3) CAEL-101 P3 success. Journey near sales targets. Multiple backup plans incl. Dotinurad & Triplex. Added to FBIOP position after initial sale.
Read full article (8 min)